See also this year's filing and all EDGAR filings for this company.
PDF Report 0001175505_2021_FIVE_Prime_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001175505, FIVE Prime Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 292,408,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,209,000 |
| 3 | remainder_Assets | 28,033,000 |
| 4 | LiabilitiesCurrent | 22,184,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 40,294,249 |
| 9 | ResearchAndDevelopmentExpense | 11,437,480 |
| 10 | remainder_Expenses | -4,247,754 |
| 11 | remainder_Revenues | 13,717,966 |
| 12 | remainder_NetIncome | 1,906,736 |
| 13 | remainder_ComprehensiveNetIncome | 2,783 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 331,650,000 |
| 1 | Liabilities | 22,184,000 |
| 2 | Expenses | 47,483,975 |
| 3 | Revenues | 13,717,966 |
| 4 | StockholdersEquity | 309,466,000 |
| 5 | NetIncome | -31,859,273 |
| 6 | ComprehensiveNetIncome | -31,857,882 |
| 7 | BaseVar | 208,472,730 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.63 |
| 9 | EconomicCapitalRatio | 4.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
